AI drug discovery company
Nabla Bio
Data as of .
Company facts
-
Founded
2020
-
Headquarters
United States (Cambridge, MA)
Latest funding round
- Round
- Series A
- Date
- May 14, 2024
- Amount
- $26M
- Lead investor
- Radical Ventures
Drug discovery partners
1 pharma. Pharma here means a company with approved products and roughly $1B or more in annual revenue.
-
Takeda Pharma
Research collaboration (second),
$1B total potential (upfront not disclosed)
Recent news
-
Takeda R&D head says an AI-designed antibody from Nabla revived a nearly terminated program (JPM 2026)
-
Signs a second Takeda collaboration on AI-designed protein therapeutics
Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.
Spot an error? Tell me and I'll fix it.